MCID: TST026
MIFTS: 39

Testicular Germ Cell Cancer malady

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Testicular Germ Cell Cancer

Aliases & Descriptions for Testicular Germ Cell Cancer:

Name: Testicular Germ Cell Cancer 12 14
Testicular Germ Cell Tumor 42 69
Testicular Malignant Germ Cell Tumor 69
Testicular Germ Cell Neoplasm 12
Germ Cell Tumor of Testis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5557
MeSH 42 C563236
NCIt 47 C8591
SNOMED-CT 64 713577007
UMLS 69 C1336708

Summaries for Testicular Germ Cell Cancer

Disease Ontology : 12 A testicular cancer that has material basis in germ cells.

MalaCards based summary : Testicular Germ Cell Cancer, also known as testicular germ cell tumor, is related to testicular germ cell tumor and pediatric testicular germ cell tumor. An important gene associated with Testicular Germ Cell Cancer is DMRT1 (Doublesex And Mab-3 Related Transcription Factor 1), and among its related pathways/superpathways are Coregulation of Androgen receptor activity and Ovarian Infertility Genes. The drugs Cisplatin and Imiquimod have been mentioned in the context of this disorder. Affiliated tissues include testis and testes, and related phenotypes are growth/size/body region and limbs/digits/tail

Related Diseases for Testicular Germ Cell Cancer

Diseases in the Testicular Germ Cell Cancer family:

Testicular Malignant Germ Cell Cancer

Diseases related to Testicular Germ Cell Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 36)
id Related Disease Score Top Affiliating Genes
1 testicular germ cell tumor 12.6
2 pediatric testicular germ cell tumor 12.2
3 testicular germ cell tumor non-seminomatous 12.1
4 pigmented villonodular synovitis 11.1
5 ulceroglandular tularemia 10.2 AR ESR2
6 borderline personality disorder 10.2 AR ESR2
7 osteogenesis imperfecta 10.2 AR ESR2
8 carbuncle 10.2 AR ESR2
9 esophagus sarcoma 10.2 ALPP AR
10 gastrointestinal tularemia 10.1 AR KITLG
11 exocervical carcinoma 10.1 AR ESR2
12 malignant teratocarcinosarcoma 10.1 ALPP AR ESR2
13 kidney benign neoplasm 10.1 ALPP ESR2
14 gallbladder papillomatosis 10.0 ALPP ESR2
15 breast myoepithelial neoplasm 10.0 ALPP AR DMRT1
16 periodic fever, aphthous stomatitis, pharyngitis and adenitis 10.0 AR LHCGR
17 acute thyroiditis 10.0 ESR2 LHCGR
18 sphingolipidosis 10.0 AR LHCGR
19 third ventricle chordoid glioma 10.0 AR LHCGR
20 dermatomyositis 9.9
21 cerebritis 9.9
22 her2-receptor positive breast cancer 9.9 AR CLPTM1L
23 avoidant personality disorder 9.9 AR ESR2 LHCGR
24 benign perivascular tumor 9.9 AR ESR2 LHCGR
25 cryptorchidism 9.8
26 thrombocytopenia 9.8
27 ulcerative colitis 9.8
28 colitis 9.8
29 hypospadias 9.8
30 estrogen excess 9.8
31 testicular cancer 9.8
32 seminoma 9.8
33 infertility 9.8
34 intussusception 9.8
35 prostate cancer, hereditary, x-linked 1 9.8 AR DMRT1 ESR2 KITLG SPRY4
36 mature teratoma 8.7 ALPP AR BLMH CLPTM1L DMRT1 ESR2

Graphical network of the top 20 diseases related to Testicular Germ Cell Cancer:



Diseases related to Testicular Germ Cell Cancer

Symptoms & Phenotypes for Testicular Germ Cell Cancer

MGI Mouse Phenotypes related to Testicular Germ Cell Cancer:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.5 AR BLMH ESR2 KITLG LHCGR PIAS1
2 limbs/digits/tail MP:0005371 9.1 AR BLMH ESR2 KITLG LHCGR SPRY4

Drugs & Therapeutics for Testicular Germ Cell Cancer

Drugs for Testicular Germ Cell Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 313)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
2
Imiquimod Approved, Investigational Phase 4 99011-02-6 57469
3 interferons Phase 4,Phase 1,Phase 2
4 Adjuvants, Immunologic Phase 4,Phase 3,Phase 1,Phase 2
5 Interferon Inducers Phase 4,Phase 1,Phase 2
6
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 50-02-2 5743
7
Vinblastine Approved Phase 3 865-21-4 13342 241903
8
Paclitaxel Approved, Vet_approved Phase 2, Phase 3, Phase 1 33069-62-4 36314
9
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
10
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
11
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
12
Bleomycin Approved Phase 2, Phase 3 11056-06-7 5360373
13
Ifosfamide Approved Phase 3,Phase 1,Phase 2 3778-73-2 3690
14
Mechlorethamine Approved Phase 3,Phase 1,Phase 2 51-75-2 4033
15
Oxaliplatin Approved, Investigational Phase 3,Phase 2 61825-94-3 5310940 9887054 6857599, 9887054 43805
16
Mesna Approved Phase 3,Phase 1,Phase 2 3375-50-6 598
17
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
18
Lenograstim Approved Phase 2, Phase 3, Phase 1 135968-09-1
19
Testosterone Approved, Investigational Phase 2, Phase 3 58-22-0 6013
20
Captopril Approved Phase 3 62571-86-2 44093
21
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
22
Ribavirin Approved Phase 3 36791-04-5 37542
23
Fluconazole Approved Phase 3 86386-73-4 3365
24
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
25
Ofloxacin Approved Phase 3 82419-36-1 4583
26
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
27 Sodium thiosulfate Approved Phase 3
28
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
29
Methyltestosterone Approved Phase 2, Phase 3 58-18-4 6010
30
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
31
Palivizumab Approved, Investigational Phase 3 188039-54-5
32
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
33
Succinylcholine Approved Phase 3,Phase 2 306-40-1 5314
34
Diphenhydramine Approved Phase 3 58-73-1, 147-24-0 3100
35
Promethazine Approved Phase 3 60-87-7 4927
36
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757 53477783
37
Mycophenolic acid Approved Phase 3 24280-93-1 446541
38
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
39
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
40
Cyproheptadine Approved Phase 3 129-03-3 2913
41
Norgestimate Approved Phase 3 35189-28-7 6540478
42
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
43
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
44 Dexamethasone acetate Phase 3,Phase 1,Phase 2 1177-87-3
45 Alkylating Agents Phase 3,Phase 1,Phase 2
46
Serotonin Phase 3,Phase 2 50-67-9 5202
47 Serotonin Agents Phase 3,Phase 2
48 Serotonin Antagonists Phase 3,Phase 2
49 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
50 Neurotransmitter Agents Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 275)
id Name Status NCT ID Phase
1 Taste, Smell and Chemotherapy (TASTY) Completed NCT01641172 Phase 4
2 Effect of Topical Imiquimod on Lentigo Maligna Completed NCT01161888 Phase 4
3 Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors Unknown status NCT00002566 Phase 3
4 Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle Unknown status NCT00589537 Phase 3
5 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3
6 Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma Unknown status NCT00004219 Phase 3
7 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3
8 Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Unknown status NCT01087268 Phase 3
9 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3
10 Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer Completed NCT00003014 Phase 3
11 Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles Completed NCT00324298 Phase 3
12 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3
13 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3
14 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3
15 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3
16 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
17 Androgen for Leydig Cell Proliferation Completed NCT01206270 Phase 2, Phase 3
18 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
19 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
20 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
21 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
22 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3
23 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
24 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
25 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed NCT00716976 Phase 3
26 Study of Testosterone vs Placebo in Testicular Cancer Survivors Recruiting NCT02991209 Phase 2, Phase 3
27 Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer Recruiting NCT02341989 Phase 3
28 Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours Recruiting NCT02582697 Phase 3
29 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3
30 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3
31 Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours Active, not recruiting NCT01726374 Phase 3
32 Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate Active, not recruiting NCT01444820 Phase 3
33 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Active, not recruiting NCT00053352 Phase 3
34 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3
35 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3
36 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3
37 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3
38 Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy Unknown status NCT00772694 Phase 2
39 Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma Unknown status NCT00183820 Phase 2
40 A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer Unknown status NCT00995358 Phase 2
41 Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) Unknown status NCT01267578 Phase 2
42 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2
43 Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer Unknown status NCT01949701 Phase 1, Phase 2
44 Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer Unknown status NCT01950156 Phase 1, Phase 2
45 A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma Unknown status NCT00183885 Phase 2
46 Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer Unknown status NCT00463060 Phase 1, Phase 2
47 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2
48 Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors Unknown status NCT01743482 Phase 2
49 Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors Unknown status NCT00127049 Phase 2
50 Promotora-based Latino Family CVD Risk Reduction Unknown status NCT01714271 Phase 2

Search NIH Clinical Center for Testicular Germ Cell Cancer

Cochrane evidence based reviews: testicular germ cell tumor

Genetic Tests for Testicular Germ Cell Cancer

Anatomical Context for Testicular Germ Cell Cancer

MalaCards organs/tissues related to Testicular Germ Cell Cancer:

39
Testis, Testes

Publications for Testicular Germ Cell Cancer

Articles related to Testicular Germ Cell Cancer:

(show top 50) (show all 112)
id Title Authors Year
1
Cisplatin-related Cerebral Infarction in Testicular Germ Cell Cancer: Short Report of Three Cases and P in testicular germ cell cancer: Short report of three cases and pathomechanism. ( 27923208 )
2017
2
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review. ( 27821802 )
2016
3
A Brief Review of the Link between Environment and Male Reproductive Health: Lessons from Studies of Testicular Germ Cell Cancer. ( 26871895 )
2016
4
Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment. ( 27873769 )
2016
5
Reply to Nahid Punjani, Nicholas Power, Eric Winquist's Letter to the Editor re: Yvonne Vergouwe, Ewout W. Steyerberg, Richard S. Foster, et al. Predicting Retroperitoneal Histology in Postchemotherapy Testicular Germ Cell Cancer: A Model Update and Multicentre Validation with More Than 1000 Patients. Eur Urol 2007;51:424-32. ( 26726124 )
2015
6
Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship. ( 25751759 )
2015
7
Re: Yvonne Vergouwe, Ewout W. Steyerberg, Richard S. Foster, et al. Predicting Retroperitoneal Histology in Postchemotherapy Testicular Germ Cell Cancer: A Model Update and Multicentre Validation with More Than 1000 Patients. Eur Urol 2007;51:424-32. ( 26726125 )
2015
8
Increasing international efforts to understand and conquer testicular germ cell cancer. ( 25711179 )
2015
9
Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. ( 25826226 )
2015
10
Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. ( 25893862 )
2015
11
Trends in testicular germ cell cancer incidence in Eastern Croatia. ( 24496357 )
2014
12
Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer. ( 24647526 )
2014
13
An oncofetal and developmental perspective on testicular germ cell cancer. ( 25066859 )
2014
14
Nodal, pulmonary and pleural gliomatosis in a 42-year-old-male with non-seminomatous testicular germ cell cancer. ( 24444134 )
2014
15
Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. ( 23395239 )
2014
16
Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer. ( 25046619 )
2014
17
Just another brick in the wall: unravelling the epigenetic mechanism underlying tumour initiation of testicular germ cell cancer. ( 24292446 )
2013
18
Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer. ( 23260006 )
2013
19
Changing epidemiologic features of testicular germ cell cancer in Germany: corroboration at population level. ( 24035419 )
2013
20
Expression analysis of RNA-binding motif gene on Y chromosome (RBMY) protein isoforms in testis tissue and a testicular germ cell cancer-derived cell line (NT2). ( 23567846 )
2013
21
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. ( 24012110 )
2013
22
Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model. ( 23098692 )
2013
23
Re: Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. ( 24120784 )
2013
24
Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer. ( 23420531 )
2013
25
Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer. ( 23770148 )
2013
26
Genome-wide assessment of the association of rare and common copy number variations to testicular germ cell cancer. ( 23372565 )
2013
27
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. ( 23169338 )
2012
28
Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer. ( 22245602 )
2012
29
Variants in KITLG predispose to testicular germ cell cancer independently from spermatogenic function. ( 22194441 )
2012
30
Replication of genetic susceptibility loci for testicular germ cell cancer in the Croatian population. ( 22745383 )
2012
31
Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis. ( 21453887 )
2011
32
Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease. ( 20880698 )
2011
33
Perinatal risk factors for childhood testicular germ-cell cancer: a Nordic population-based study. ( 21846595 )
2011
34
Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. ( 21062302 )
2011
35
Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients. ( 21346388 )
2011
36
Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information. ( 21696394 )
2011
37
Is testicular germ cell cancer associated with increased muscle mass or adiposity? ( 21253772 )
2011
38
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients. ( 21347634 )
2011
39
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. ( 20543847 )
2010
40
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer. ( 19922501 )
2010
41
Canadian consensus guidelines for the management of testicular germ cell cancer. ( 20368885 )
2010
42
Familial coaggregation of cryptorchidism, hypospadias, and testicular germ cell cancer: a nationwide cohort study. ( 20026812 )
2010
43
Burden or relief: do second-opinion centers influence the quality of care delivered to patients with testicular germ cell cancer? ( 19931248 )
2010
44
Testicular germ cell cancer incidence in an immigration perspective, Denmark, 1978 to 2003. ( 20171682 )
2010
45
Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer. ( 19440001 )
2009
46
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. ( 19483682 )
2009
47
Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. ( 19010497 )
2009
48
Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker. ( 19154496 )
2009
49
Physical activity in adolescence and testicular germ cell cancer risk. ( 19399630 )
2009
50
Increased risk of testicular germ cell cancer among infertile men. ( 19237718 )
2009

Variations for Testicular Germ Cell Cancer

Expression for Testicular Germ Cell Cancer

Search GEO for disease gene expression data for Testicular Germ Cell Cancer.

Pathways for Testicular Germ Cell Cancer

Pathways related to Testicular Germ Cell Cancer according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.71 AR PIAS1
2 10.13 ESR2 LHCGR

GO Terms for Testicular Germ Cell Cancer

Biological processes related to Testicular Germ Cell Cancer according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription from RNA polymerase II promoter GO:0000122 9.46 AR DMRT1 ESR2 PIAS1
2 steroid hormone mediated signaling pathway GO:0043401 9.32 AR ESR2
3 androgen receptor signaling pathway GO:0030521 9.26 AR PIAS1
4 sex differentiation GO:0007548 8.96 AR DMRT1
5 male gonad development GO:0008584 8.92 AR DMRT1 KITLG LHCGR

Molecular functions related to Testicular Germ Cell Cancer according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 steroid hormone receptor activity GO:0003707 9.16 AR ESR2
2 RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding GO:0004879 8.96 AR ESR2
3 steroid binding GO:0005496 8.62 AR ESR2

Sources for Testicular Germ Cell Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....